Ipagala Pius, Mlugu Eulambius M, Mwakalukwa Rogers, Kagashe Godeliver A
Department of Pharmaceutics and Pharmacy Practice, School of Pharmacy, Muhimbili University of Health and Allied Sciences, P.O. Box 65013, Dar es Salaam, Tanzania.
Department of Pharmacognosy, School of Pharmacy, Muhimbili University of Health and Allied Sciences, P.O. Box 65013, Dar es Salaam, Tanzania.
J Pharm Policy Pract. 2023 Sep 22;16(1):103. doi: 10.1186/s40545-023-00617-1.
The outbreak of COVID-19 in the late 2019 led to major global health crises, including morbidities and mortalities. The pandemic has adversely affected the supply chain of essential health commodities globally. However, such data from sub-Saharan Africa including Tanzania are largely limited. We assessed the impact of COVID-19 on the supply chain of essential health commodities in Tanzania.
A cross-sectional study with pragmatic mixed method design was conducted in Dar es Salaam region from January to June 2021. Grounded theory was adopted to purposeful select key informants (n = 15) from importers of essential health commodities and local pharmaceutical manufacturers. Community pharmacy dispensers (n = 242) were also recruited for the quantitative part of this study. The prices of selected tracer health commodities were extracted from the Tanzania Medicine and Medical Device Authority (TMDA) Regulatory Information Management system. The mean unit prices 1 year before the pandemic were compared with the mean prices 1 year during the pandemic using paired t test. Thematic analysis was used for qualitative data.
The information regarding the impact of COVID-19 on the supply chain of essential health commodities was synthesized into three main themes namely, reduced availability of health commodities, increased price of health commodities and increased lead time for imported essential health commodities during COVID-19. Majority (90%) of community pharmacy dispensers reported that COVID-19 reduced the availability of essential health commodities. Azithromycin, Paracetamol, Multivitamin and Vitamin C tablets were the highly demanded products and their mean unit prices increased significantly during COVID-19 as compared to 1 year before the pandemic (p < 0.05).
COVID-19 led to shortage, increased prices and delayed delivery of essential health commodities. This might happen in the future whenever unexpected crises causing disruption in the supply chain occur underscoring the need for the country preparedness measures.
2019年末新冠疫情的爆发引发了重大全球健康危机,包括发病和死亡情况。这场大流行对全球基本医疗用品的供应链产生了不利影响。然而,来自撒哈拉以南非洲地区(包括坦桑尼亚)的此类数据非常有限。我们评估了新冠疫情对坦桑尼亚基本医疗用品供应链的影响。
2021年1月至6月在达累斯萨拉姆地区进行了一项采用务实混合方法设计的横断面研究。采用扎根理论从基本医疗用品进口商和当地药品制造商中有目的地挑选关键信息提供者(n = 15)。还招募了社区药房药剂师(n = 242)参与本研究的定量部分。从坦桑尼亚药品和医疗器械管理局(TMDA)监管信息管理系统中提取选定追踪医疗用品的价格。使用配对t检验比较大流行前1年的平均单价与大流行期间1年的平均价格。对定性数据采用主题分析。
关于新冠疫情对基本医疗用品供应链影响的信息被归纳为三个主要主题,即医疗用品可获得性降低、医疗用品价格上涨以及新冠疫情期间进口基本医疗用品的交货时间延长。大多数(90%)社区药房药剂师报告称,新冠疫情降低了基本医疗用品的可获得性。阿奇霉素、对乙酰氨基酚、多种维生素和维生素C片是需求旺盛的产品,与大流行前1年相比,其在新冠疫情期间的平均单价显著上涨(p < 0.05)。
新冠疫情导致基本医疗用品短缺、价格上涨和交货延迟。每当出现导致供应链中断的意外危机时,未来可能都会发生这种情况,这突出了国家防范措施的必要性。